The field of cancer immunotherapy is developing quickly. Accordingly, there is a need for novel imaging modalities. Hear from Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, Quintiles, about immuno-PET technology and the importance of following changes in a patient’s immune system without having to take a biopsy or blood sample.